These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21595303)

  • 61. Drug nanocrystals in the commercial pharmaceutical development process.
    Möschwitzer JP
    Int J Pharm; 2013 Aug; 453(1):142-56. PubMed ID: 23000841
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nano-sized crystalline drug production by milling technology.
    Moribe K; Ueda K; Limwikrant W; Higashi K; Yamamoto K
    Curr Pharm Des; 2013; 19(35):6246-58. PubMed ID: 23470002
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Towards sustainability: new approaches to nano-drug preparation.
    Cheow WS; Xu R; Hadinoto K
    Curr Pharm Des; 2013; 19(35):6229-45. PubMed ID: 23469999
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Is Ultrasound as a Milling or Pre-Milling Method to Prepare Aqueous Suspensions an Effective Approach?
    Zulbeari N; Holm R
    J Pharm Sci; 2024 Jul; 113(7):2001-2003. PubMed ID: 38642708
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Process and scaling parameters for wet media milling in early phase drug development: A knowledge based approach.
    Siewert C; Moog R; Alex R; Kretzer P; Rothenhäusler B
    Eur J Pharm Sci; 2018 Mar; 115():126-131. PubMed ID: 29278757
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recent advancements in mechanical reduction methods: particulate systems.
    Leleux J; Williams RO
    Drug Dev Ind Pharm; 2014 Mar; 40(3):289-300. PubMed ID: 23988193
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improvement of dissolution property of poorly water-soluble drug by novel dry coating method using planetary ball mill.
    Sonoda R; Horibe M; Oshima T; Iwasaki T; Watano S
    Chem Pharm Bull (Tokyo); 2008 Sep; 56(9):1243-7. PubMed ID: 18758094
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Influence of solvent on the morphology and subsequent comminution of ibuprofen crystals by air jet milling.
    Shariare MH; Blagden N; de Matas M; Leusen FJ; York P
    J Pharm Sci; 2012 Mar; 101(3):1108-19. PubMed ID: 22161641
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Formulation and Stability of Solutions.
    Akers MJ
    Int J Pharm Compd; 2016; 20(1):41-5. PubMed ID: 27127830
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size.
    Sinha B; Müller RH; Möschwitzer JP
    Int J Pharm; 2013 Aug; 453(1):126-41. PubMed ID: 23333709
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of critical process parameters and its interplay with nanosuspension formulation prepared by top down media milling technology--a QbD perspective.
    Ghosh I; Schenck D; Bose S; Liu F; Motto M
    Pharm Dev Technol; 2013; 18(3):719-29. PubMed ID: 23061898
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of in-line Raman spectroscopic monitoring of size reduction during wet media milling of Biopharmaceutics Classification System Class II drugs.
    Ying Y; Afolabi A; Bilgili E; Iqbal Z
    Appl Spectrosc; 2014; 68(12):1411-7. PubMed ID: 25356951
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Disintegration rate and properties of active pharmaceutical ingredient particles as determined from the dissolution time profile of a pharmaceutical formulation: an inverse problem.
    Horkovics-Kovats S
    J Pharm Sci; 2014 Feb; 103(2):456-64. PubMed ID: 24338791
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Extruder scale-up assessment in the process of extrusion-spheronization: comparison of radial and axial systems by a design of experiments approach.
    Désiré A; Paillard B; Bougaret J; Baron M; Couarraze G
    Drug Dev Ind Pharm; 2013 Feb; 39(2):176-85. PubMed ID: 23216219
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs.
    Bhakay A; Merwade M; Bilgili E; Dave RN
    Drug Dev Ind Pharm; 2011 Aug; 37(8):963-76. PubMed ID: 21323486
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Engineering of acetaminophen particle attributes using a wet milling crystallisation platform.
    Ahmed B; Brown CJ; McGlone T; Bowering DL; Sefcik J; Florence AJ
    Int J Pharm; 2019 Jan; 554():201-211. PubMed ID: 30391338
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Recent advances in techniques for enhancing the solubility of hydrophobic drugs.
    Xu Z; Lin S; Li Q; Jiang S; Wang P
    Pak J Pharm Sci; 2022 Jan; 35(1):95-112. PubMed ID: 35221278
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Basic Principles of Lyophilization, Part 2.
    Akers MJ
    Int J Pharm Compd; 2016; 20(1):20-7. PubMed ID: 27125053
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Particle size reduction using acoustic cavitation].
    Bartos C; Ambrus R; Szabóné RP
    Acta Pharm Hung; 2014; 84(4):131-5. PubMed ID: 25872275
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Spheronization process particle kinematics determined by discrete element simulations and particle image velocimentry measurements.
    Koester M; García RE; Thommes M
    Int J Pharm; 2014 Dec; 477(1-2):81-7. PubMed ID: 25304094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.